Cerus reported $-8983000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Atrion ATRI:US 14.48M 3.28M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Cytori Therapeutics CYTX:US $ -4.96M 1.19M
Haemonetics HAE:US $ 51.92M 60.37M
Nuvasive NUVA:US $ 61.93M 10.14M
Rockwell Medical RMTI:US $ -4.24M 2.14M
Sientra SIEN:US $ -14.28M 0.07M